These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3339634)

  • 1. The prevalence of antibody to human parvovirus B19 in England and Wales.
    Cohen BJ; Buckley MM
    J Med Microbiol; 1988 Feb; 25(2):151-3. PubMed ID: 3339634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of parvovirus B19 infection in women of childbearing age in England and Wales.
    Vyse AJ; Andrews NJ; Hesketh LM; Pebody R
    Epidemiol Infect; 2007 Nov; 135(8):1354-62. PubMed ID: 17291377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy?
    Gay NJ; Hesketh LM; Cohen BJ; Rush M; Bates C; Morgan-Capner P; Miller E
    Commun Dis Rep CDR Rev; 1994 Aug; 4(9):R104-7. PubMed ID: 7522807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Seroprevalence of human parvovirus B 19 antibodies (Sticker's disease/erythema infectiosum) in the DRG population].
    Wiersbitzky S; Schwarz TF; Bruns R; Jäger G; Bittner S; Weidemann H; Deinhardt F; Hottenträger B; Abel E; Ladstätter L
    Kinderarztl Prax; 1990 Apr; 58(4):185-9. PubMed ID: 2164118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of anti-human parvovirus antibody in pregnant women].
    Yaegashi N; Okamura K; Hamazaki Y; Yajima A; Shiraishi H; Sugamura K
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):162-6. PubMed ID: 2179428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence of parvovirus B19 infection. Seroepidemiologic studies].
    Schwarz TF; Roggendorf M; Deinhardt F
    Dtsch Med Wochenschr; 1987 Oct; 112(40):1526-31. PubMed ID: 2820687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Parvovirus B19 infections in Germany 1987-1988].
    Schwarz TF; Jäger G; Schlipköter UA; Wiersbitzky S; Tiller FW; Hottenträger B; Deinhardt F; Roggendorf M
    Offentl Gesundheitswes; 1990 Feb; 52(2):53-7. PubMed ID: 2158028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of human parvovirus B19 infection in Sao Tomé and Principe, Malawi and Mascarene Islands.
    Schwarz TF; Gürtler LG; Zoulek G; Deinhardt F; Roggendorf M
    Zentralbl Bakteriol; 1989 Jul; 271(2):231-6. PubMed ID: 2550018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil.
    Nascimento JP; Buckley MM; Brown KE; Cohen BJ
    Rev Inst Med Trop Sao Paulo; 1990; 32(1):41-5. PubMed ID: 2175446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].
    Türk Dağı H; Ozdemir M; Baykan M; Baysal B
    Mikrobiyol Bul; 2010 Jul; 44(3):467-72. PubMed ID: 21063997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response to B19 parvovirus and an antibody defect in persistent viral infection.
    Kurtzman GJ; Cohen BJ; Field AM; Oseas R; Blaese RM; Young NS
    J Clin Invest; 1989 Oct; 84(4):1114-23. PubMed ID: 2551923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of parvovirus B19 IgG antibodies among Dutch hemophilia patients.
    Mauser-Bunschoten EP; Zaaijer HL; van Drimmelen AA; de Vries S; Roosendaal G; van den Berg HM; Lelie PN
    Vox Sang; 1998; 74(4):225-7. PubMed ID: 9691402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany.
    Enders M; Weidner A; Enders G
    Epidemiol Infect; 2007 May; 135(4):563-9. PubMed ID: 17064457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
    Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
    J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
    Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
    J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of parvovirus B19 in the German population.
    Röhrer C; Gärtner B; Sauerbrei A; Böhm S; Hottenträger B; Raab U; Thierfelder W; Wutzler P; Modrow S
    Epidemiol Infect; 2008 Nov; 136(11):1564-75. PubMed ID: 18198003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].
    Wei Q; Li Y; Wang JW; Wang H; Qu JG; Hung T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):60-2. PubMed ID: 16816866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of antibodies to parvovirus B19 among children in Papua New Guinea.
    Wildig J; Mueller I; Kiniboro B; Maraga S; Siba P; Cossart Y
    Am J Trop Med Hyg; 2007 Aug; 77(2):354-7. PubMed ID: 17690412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroprevalence of IgG antibodies against parvovirus B19 in the population of the Czech Republic].
    Sodja I; Mrázová M; Smelhausová M; Kotrbová K; Pazdiora P; Bruj J; Stojanov I; Kadlecík D; Sámal J
    Epidemiol Mikrobiol Imunol; 1995 Dec; 44(4):171-4. PubMed ID: 8556246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.